← Eichor
Condition: Patient Activation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Patient Activation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease.
Phase N/A · 1 location(s) · Odense University Hospital · NCT05266092Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Phase 2 · 1 location(s) · TYK Medicines, Inc · NCT05948813Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia
NA · 1 location(s) · ShangHai Ji Ai Genetics & IVF Institute · NCT06561451Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation
Phase N/A · 1 location(s) · Sanjay Gandhi Postgraduate Institute of Medical Sciences · NCT06520605Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be M
Phase N/A · 1 location(s) · University of Pennsylvania · NCT07125079Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · 15 location(s) · SOFIE · NCT07217717A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Phase 1 · 6 location(s) · Cogent Biosciences, Inc. · NCT07361562An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Phase N/A · 1 location(s) · Blueprint Medicines Corporation · NCT07264959Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
Phase 2 · 1 location(s) · CellSight Technologies, Inc. · NCT06107374Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD
Phase N/A · 1 location(s) · Lauro Gutiérrez Castro · NCT07595614Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
Phase N/A · 1 location(s) · Swiss Paraplegic Research, Nottwil · NCT03037684Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Phase N/A · 1 location(s) · Zhongda Hospital · NCT0757373568Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT0727318818F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07077213JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Phase 3 · 191 location(s) · Johnson & Johnson Enterprise Innovation Inc. · NCT04892173X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Phase 1 · 4 location(s) · Immunolight, LLC · NCT04389281Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers
EARLY_Phase 1 · 1 location(s) · Hainan Cancer Hospital · NCT07475182Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thromboc
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06033300Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Rece
NA · 1 location(s) · VA Office of Research and Development · NCT04877197Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
NA · 5 location(s) · University of Pittsburgh · NCT04109820Study of Patients with Electrical Status Epilepticus in Sleep
Phase N/A · 1 location(s) · East Suffolk and North Essex NHS Foundation Trust · NCT06792396Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT03255928A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Phase 2 · 39 location(s) · Swedish Orphan Biovitrum · NCT06782373Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Phase 3 · 1 location(s) · Shanghai Kechow Pharma, Inc. · NCT06008106Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
NA · 1 location(s) · Xiong Juyang · NCT07552571Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
Phase N/A · 2 location(s) · University of Thessaly · NCT06958016A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Ac
Phase 1/Phase 2 · 74 location(s) · Nuvalent Inc. · NCT05384626Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (An
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039632
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.